Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes. | Noncoding RNA Res | 2022 | 35702574 | PubTator, text mining | PubMed |
| Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors. | Target Oncol | 2022 | 35699834 | PubTator, text mining | PubMed |
| Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors. | Int J Mol Sci | 2022 | 35682627 | PubTator, text mining | PubMed |
| The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders. | Int J Mol Sci | 2022 | 35682599 | PubTator, text mining | PubMed |
| New Therapeutic Strategies for Adult Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35681786 | PubTator, text mining | PubMed |
| Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use. | Cancers (Basel) | 2022 | 35681619 | PubTator, text mining | PubMed |
| [The efficacy and safety of CLAG-M/I regimen for relapsed or refractory acute myeloid leukemia in children]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680635 | PubTator, text mining | PubMed |
| [Clinical and genetic characteristics of patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective of 790 cases]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680634 | PubTator, text mining | PubMed |
| [Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35680626 | PubTator, text mining | PubMed |
| Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma. | J Immunol Res | 2022 | 35677537 | PubTator, text mining | PubMed |
| Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia. | Cytogenet Genome Res | 2022 | 35675801 | PubTator, text mining | PubMed |
| [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia]. | Nan Fang Yi Ke Da Xue Xue Bao | 2022 | 35673912 | PubTator, text mining | PubMed |
| CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML. | Front Pharmacol | 2022 | 35662693 | PubTator, text mining | PubMed |
| Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation. | Bone Marrow Transplant | 2022 | 35661835 | PubTator, text mining | PubMed |
| Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD+ AML Cells. | Front Cell Dev Biol | 2022 | 35656547 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review. | Cancer Manag Res | 2022 | 35637940 | PubTator, text mining | PubMed |
| Microtransplantation for myeloid sarcoma: Two case reports. | Leuk Res Rep | 2022 | 35634196 | PubTator, text mining | PubMed |
| New Insights into Hematopoietic Stem Cell Expansion to Stimulate Repopulation of the Adult Blood System for Transplantation. | Life (Basel) | 2022 | 35629383 | PubTator, text mining | PubMed |
| Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents. | Int J Mol Sci | 2022 | 35628480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=36